Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Cash Flows

v3.25.4
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:    
Net income $ 2,266,722 $ 1,770,378
Adjustments to reconcile net income to net cash provided by operating activities:    
Impairment of goodwill and purchased intangible assets 0 239,100
Depreciation and amortization 196,284 199,745
Unrealized foreign exchange loss and other 14,382 19,064
Stock-based compensation expense 144,129 123,541
Net gain on sale of assets 0 (161)
Deferred income taxes (42,343) (150,658)
Changes in assets and liabilities:    
Accounts receivable 178,583 (486,264)
Inventories (94,524) 5,632
Other assets (14,346) 61,796
Accounts payable (28,707) 54,617
Deferred system revenue 41,259 86,709
Deferred service revenue (27,052) 58,790
Other liabilities (105,189) (137,536)
Net cash provided by operating activities 2,529,198 1,844,753
Cash flows from investing activities:    
Proceeds from sale of assets 0 161
Capital expenditures (201,470) (152,716)
Proceeds from capital-related government assistance 16,782 0
Purchases of available-for-sale and equity securities (1,811,484) (1,326,968)
Proceeds from maturity and sale of available-for-sale securities 1,473,704 1,921,004
Purchases of trading securities (180,808) (34,857)
Proceeds from sale of trading securities 180,606 36,043
Net cash provided by (used in) investing activities (522,670) 442,667
Cash flows from financing activities:    
Payment of debt issuance costs (1,602) 0
Repayment of debt 0 (750,000)
Common stock repurchases (1,092,817) (1,217,504)
Payment of dividends to stockholders (503,662) (424,855)
Issuance of common stock 55,542 47,538
Tax withholding payments related to vested and released restricted stock units (86,839) (75,854)
Net cash used in financing activities (1,629,378) (2,420,675)
Effect of exchange rate changes on cash and cash equivalents (3,934) (5,596)
Net increase (decrease) in cash and cash equivalents 373,216 (138,851)
Cash and cash equivalents at beginning of period 2,078,908 1,977,129
Cash and cash equivalents at end of period 2,452,124 1,838,278
Supplemental cash flow disclosures:    
Income taxes paid, net 402,950 458,228
Interest paid, net of capitalized interest 139,194 156,185
Non-cash activities:    
Dividends payable - financing activities 4,437 4,113
Unsettled common stock repurchase - financing activities 5,500 5,500
Accrued purchases of land, property and equipment - investing activities $ 26,040 $ 11,354